Stainless Steel IBCs in Pharma: What The Regulations Don't Tell You

By the team at Shijiazhuang Fulait Packaging Co., LTD

A quality manager at a generic drug manufacturer in India called us with a headache.

Their auditor had flagged their stainless steel IBCs. Not for contamination—for "lack of documented surface finish specifications."

The auditor's question: "How do you know your containers aren't trapping residue in microscopic scratches?"

They didn't have an answer. We gave them one.

The Unwritten Rules of Pharma IBCs

Here's what the regulations actually say:

• FDA 21 CFR 177 talks about materials

• USP <88> covers biological reactivity

• GMP guidelines mention cleanability

But what they don't tell you is how to prove it.

After 15 years supplying pharma companies, here's what we've learned actually matters:

The "Ah Ha!" Moment: It's About Validation, Not Just Cleaning

Most pharma companies know how to clean.

The hard part? Proving it's clean.

This is where stainless steel IBCs earn their keep.

A sterile fill contractor in Germany switched from disposable liners to our 316L IBCs. Their validation protocol:

1. Soil the IBC with a known contaminant

2. Run their CIP cycle

3. Swab test at 10 critical points

4. Send swabs for HPLC analysis

Pass rate with plastic IBCs: 73%
Pass rate with our polished 316L IBCs: 98%

The difference? Those microscopic scratches in plastic—and even in poorly polished stainless—can hide residue.

Three Pharma Applications Where IBCs Shine

1. API Intermediates

Before the final active ingredient, there's the intermediate. Often in solvent. Often valuable. Often needs clean transfer between reactors.

Our IBCs with tri-clamp connections and mirror-polished interiors are built for this.

2. Buffer Solutions

Biopharma runs on buffers. And buffers are notoriously hard on equipment—some are alkaline, some are salty.

316L with electropolished surface handles them all.

3. WFI (Water for Injection)

The purest water on earth. It's so pure it wants to leach ions from whatever touches it.

Only properly passivated 316L or better can handle WFI without contaminating it.

The Documentation Package Pharma Buyers Need

If you're buying IBCs for pharma, ask your supplier for:

1. 3.1 material certificates for all wetted parts

2. Surface finish reports with Ra values

3. Weld maps showing every weld is inspected

4. Passivation certificates (nitric or citric)

5. Cleaning validation support if needed

We provide all of this as standard for pharma customers.

A Story About What "Clean Enough" Costs

A biotech startup in Boston bought cheap IBCs from a trader. Saved $3,000 on five tanks.

First batch of their experimental drug failed QA. Traces of the previous user's product found in the tank.

Investigation cost: $15,000
Lost batch value: $80,000
Delayed clinical trial: Priceless

They now buy from us. Their QA director's words: "I don't care if they cost twice as much. I need to know exactly what's in that tank."

The "Good Enough" Trap

In pharma, "good enough" isn't.

If your IBC isn't documented, it didn't happen.

If your surface finish isn't verified, assume it's not smooth enough.

If your welds aren't mapped, they're suspect.

We built our pharma-grade IBCs around this thinking. Every tank ships with a binder thicker than most novels.

Need Help Specifying for Pharma?

Drop a line to admin@stainlesssteelibc.com with your application.

We'll send you a spec sheet that covers what your auditor will ask—before they ask it.